Genetic Signatures (ASX:GSS) said its Chief Financial and Operating Officer, Karl Pechmann, resigned and he will leave his position effective Jan. 30, 2026, according to a Tuesday ASX filing.
The firm said that interim arrangements will be put in place to ensure continuity of operations.